The mixed quarter (revenue miss but AOI beat and strong debt reduction) suggests the stock may trade on the margin improvement and deleveraging story rather than top-line growth. Watch for the November guidance update as the key catalyst — if the new CEO's full-year outlook signals accelerating organic growth, the stock could re-rate higher. The SDC execution issues are a near-term overhang.
Price Chart
Executive Summary
Mesa Laboratories reported Q1 FY2027 revenue of $60.1M (+1.0% YoY), slightly below the $60.9M consensus. GAAP EPS was $0.49, a 42% decline YoY due to non-operating FX losses, while non-GAAP adjusted operating income (AOI) per diluted share was $2.61, beating the $2.55 consensus. The company repaid $8.7M in debt, reducing leverage to 1.85x, and management will issue full-year guidance in November alongside first-half results, signaling a wait-and-see approach on the new CEO's strategy.
Key Financial Metrics
Key Facts
- Revenue of $60.1M (+1.0% YoY) slightly missed $60.9M consensus.
- GAAP EPS of $0.49 declined 42% YoY due to $2.7M in non-operating FX losses vs. $3.9M FX gains in the prior year.
- Non-GAAP AOI per diluted share of $2.61 beat the $2.55 consensus estimate.
- Non-GAAP AOI margin expanded to 25.6% of revenue from 21.7% a year ago.
- Debt repayment of $8.7M reduced Total Net Leverage Ratio to 1.85x, well below the 2.0x target.
- Full-year guidance will be provided in November alongside first-half results; no near-term outlook was given.
- SDC division revenue declined 3.6% organically due to fulfillment and delivery execution issues.
- BPD (+5.0%), CS (+7.6%), and CG (-0.1%) showed mixed organic growth trends.
Financial Impact
Revenue $60.1M vs. $60.9M consensus (-1.3% miss); GAAP EPS $0.49 vs. consensus not provided; Non-GAAP AOI EPS $2.61 vs. $2.55 consensus (+2.4% beat).
Risk Factors
- SDC division's fulfillment and delivery challenges may persist, weighing on near-term revenue.
- No full-year guidance provided until November creates uncertainty around the growth trajectory.
- GAAP EPS decline driven by FX volatility could recur if currency markets remain unstable.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3342185 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 13, 2026 13d ago | 8-K | $127.56 | awaiting T+20 | — | $129.87 (+1.81%) |
Oct 13, 2026 13d ago | Press Release | $127.56 | awaiting T+20 | — | $129.87 (+1.81%) |
Oct 9, 2026 17d ago | SC 13G | $127.51 | awaiting T+20 | — | $129.87 (+1.85%) |
Aug 17, 2026 10w ago | Insider Cluster | $107.64 $127.15 | ▲ +18.13% | ▲ +20.10% | $129.87 (+20.65%) |
Aug 17, 2026 10w ago | Insider Cluster | $107.64 $127.15 | ▲ +18.13% | ▲ +20.10% | $129.87 (+20.65%) |
Aug 17, 2026 10w ago | Insider Cluster | $107.64 $127.15 | ▲ +18.13% | ▲ +20.10% | $129.87 (+20.65%) |
Aug 17, 2026 10w ago | Insider Cluster | $107.64 $127.15 | ▲ +18.13% | ▲ +20.10% | $129.87 (+20.65%) |
Aug 10, 2026 11w ago | 8-K | $111.23 $123.91 | ▲ +11.40% | ▲ +12.46% | $129.87 (+16.76%) |
Aug 10, 2026 11w ago | Press Release | $111.23 $123.91 | ▲ +11.40% | ▲ +12.46% | $129.87 (+16.76%) |
Jul 6, 2026 16w ago | Press Release | $102.56 $100.81 | ▼ −1.71% | ▼ −1.14% | $129.87 (+26.63%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers